Boris V. Nikonenko
Sequella
Inc., 9610 Medical Center Drive
Rockville
USA
Name/email consistency: high
- Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis. Nikonenko, B.V., Reddy, V.M., Protopopova, M., Bogatcheva, E., Einck, L., Nacy, C.A. Antimicrob. Agents Chemother. (2009)
- Preclinical study of new TB drugs and drug combinations in mouse models. Nikonenko, B.V., Sacksteder, K.A., Hundert, S., Einck, L., Nacy, C.A. Recent. Patents. Anti-infective. Drug. Discovery (2008)
- Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs. Nikonenko, B.V., Protopopova, M., Samala, R., Einck, L., Nacy, C.A. Antimicrob. Agents Chemother. (2007)
- Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis. Nikonenko, B.V., Samala, R., Einck, L., Nacy, C.A. Antimicrob. Agents Chemother. (2004)